Business · 02/04/2014Updated: 10/17/2026 · 1 min read
FDA Clears Nimodipine Capsules for Sale, Rejects Withdrawal Request
Summary
The US Food and Drug Administration (FDA) has ruled that NIMOTOP (Nimodipine) Capsules, 30 milligrams, were not withdrawn from sale due to safety or effectiveness concerns, allowing the drug to remain on the market.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →